A Functional Anti-Human 4-1BB Ligand Monoclonal Antibody that Enhances Proliferation of Monocytes by Reverse Signaling of 4-1BBL

Hybridoma and Hybridomics

Volumn 22, Issue 5, 2003, Pages 333-338

  Ju, Song Wen ^a   Ju, Song Guang ^a   Wang, Feng Ming ^a   Gu, Zong Jiang ^a   Qiu, Yu Hua ^a   Yu, Ge Hua ^a   Ma, Hong Bing ^a   Zhang, Xue Guang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4 1BB; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BLOOD; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALIA;

EID: 0345257063     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/153685903322538872     Document Type: Article

References (31)

1. Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, Okumura K, and Watts TH: 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol 2001;167:1313-1324.
2. Melero I, Bach N, Hellstrom KE, Aruffo A, Mittler RS, and Chen L: Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur J Immunol 1998;28:1116-1121.
3. Hurtado JC, Kim SH, Pollok KE, Lee ZH, and Kwon BS: Potential role of 4-1BB in T cell activation: Comparison with the costimulatory molecule CD28. J Immunol 1995;155:3360-3367.
4. - T lymphocytes by 4-1BB ligand. J Immunol 1997;158:551-559.
5. Saoulli K, Lee SY, Cannons JL, Yeh WC, Santanna A, Goldstein MD, Bangia N, DeBedette MA, Mak TW, Choi Y, et al: CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998;187:1849-1862.
6. Diehl L, van Mierlo GJ, den Boer AT, van der Voort E, Fransen M, van Bostelen L, Krimpenfort P, Melief CJ, Mittler R, Toes RE, et al: In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J Immunol 2002;168:3755-3762.
7. Goodwin RG, Din WS, Davis-Smith T, Anderson DM, Gimpel SD, Sato TA, Maliszewski CR, Brannan CI, Copeland NG, Jenkins NA, et al: Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 1993;23:2631.
8. Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, and Kwon BS: Characterization of human homologue of 4-1BB and its ligand. Immunol Lett 1995;45:67-73.
9. Alderson, MR, Smith CA, Tough TW, Davis-Smith T, Armitage RJ, Falk B, Roux E, Baker E, Sutherland GR, Din WS, et al: Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994;24:2219-2227.
10. DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS, and Watts TH: Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995;181:985-992.
11. DeBenedette MA, Wen T, Bachmann MF, Ohashi PS, Barber BH, Stocking KL, Peschon JJ, and Watts TH: Analysis of 4-1BB ligand (4-1BBL)-dificient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 1999;163:4833-4841.
12. Tan JT, Whitmire JK, Ahmed R, Pearson TC, and Larsen CP: 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 1999;163: 4859-4868.
13. Stuber E, Neurath M, Calderhead D, Fell HP, and Strober W: Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2:507-521.
14. Grewal IS, Xu J, and Flavell RA: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995;378: 617-620.
15. Van Essen D, Kikutani H, and Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995;378:620-623.
16. Wiley RW, Goodwin RG, and Smith CA: Reverse signaling via CD30 ligand. J Immunol 1996;157:3635-3639.
17. Langstein J, Michel J, and Schwarz H: CD137 induces proliferation and endomitosis in monocytes. Blood 1999;94:3161-3168.
18. Langstein J, Michel J, Fritsche J, Kreutz M, Andreesen R, and Schwarz H: CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via reverse signaling. J Immunol 1998;160:2488-2494.
19. Kienzle G, and von Kempis J: CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol 2000;12:73-82.
20. Langstein J, and Schwarz H: Identification of CD137 as a potent monocyte survival factor. Leukocyte Biol 1999;65:829-833.
21. Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, and Kiener PA: Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J Immunol 2000;165:2903-2910.
22. Groth SF, and Scheidegger D: Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980;35:1-21.
23. Gruss HJ, and Dower SK: Tumor necrossi factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-3404.
24. Gruss HJ: Molecular, structure, and biological characteristic of the tumor necorosisi factor ligand superfamily. Int J Lab Res 1996;26:143-159.
25. Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, and Kwon BS: 4-1BB T cell antigen binds to mature B cells and macrophages and costimulates anti μ-primed splenic B cells. Eur J Immunol 1994;24:367-374.
26. Schwarz H, Valbracht J, Tuckwell J, von Kempis J, and Lotz M: ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T lymphocyte proliferation and survival. Blood 1996;87:2839-2845.
27. Michel J, Pauly S, Langstein P, Krammer PH, and Schwarz H: CD137-induced apoptosis is independent of CD95. Immunology 1999;98:42-6.
28. Watts AD, Hunt NH, Wanigasekaral Y, Bloomfield G, Wallach D, Roufogalis BD, and Chaudhri G: A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signalling." EMBO J 1999;18:2119-2126.
29. Unanue ER, and Allen PM: The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987;236: 551-557.
30. Nathan, CF: Secretory products of macrophages. J Clin Invest 1987;79:319-326.
31. Kienzle G, and von Kempis J: CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol 2000;12:73-82.